Premium
SIMULTANEOUS BET/CREBBP/EP300 TARGETING APPROACH COMPARED TO SINGLE BET OR CREBBP/EP300 INHIBITION IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)
Author(s) -
Spriano F.,
Gaudio E.,
Tarantelli C.,
Golino G.,
Cascione L.,
Zucca E.,
Stathis A.,
Giles F.,
Bertoni F.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.196_2631
Subject(s) - bromodomain , creb binding protein , diffuse large b cell lymphoma , cancer research , bet inhibitor , lymphoma , ibrutinib , chemistry , bcl6 , microbiology and biotechnology , biology , transcription factor , creb , b cell , epigenetics , biochemistry , chronic lymphocytic leukemia , leukemia , immunology , germinal center , gene , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom